Symrise Ag

Universitat Wien

Veronika Somoza

Jakob Peter Ley

Gerhard Krammer

Susanne Paetz

Katharina Reichelt

Sabine Widder

Joachim Hans

Maria Blings

Kathrin Liszt

Mark Somoza

Barbara Rohm

Silke Middendorf

Marc Pignitter

Christina Hochkogler

Elke Köck

Matthias Zaunschirm

Martin Gurney

Katharina Schüller

Leopoldo Beltran

Marcus Götz

Katharina Zakovsek

Mathias Zaunschirm

Kathrin Ingrid Liszt

Jessica Walker

Joel Michael Walker

The present invention refers to a composition comprising guaifenesin and one or more flavour compound(s) containing an isovanillyl group. In particular, the present invention refers to a composition comprising guaifenesin and one or more flavour compound(s) containing an isovanillyl group, said composition being for medical use, in particular for use in the prevention and treatment of respiratory diseases. Moreover, the present invention relates to the use of guaifenesin and one or more flavour compounds containing an isovanillyl group for the preparation of a pharmaceutical composition. Finally, the present invention relates to the use of one or more flavour compound(s) containing an isovanillyl group for masking or inhibiting the bitter taste of guaifenesin or of guaifenesin comprising compositions.

Compositions comprising guaifenesin and flavour compounds containing an isovanillyl group

The present invention belongs to the area of pharmaceutical and cosmetic compositions and refers to compounds, novel mixtures and preparations comprising certain compound(s) of formula (I) which show anti-inflammatory properties.

Dihydrochalcone derivatives influencing inflammatory states

The present invention primarily relates to the use of Homoeriodictyol (HED) or a salt thereof or a mixture of HED and one or more salts thereof or a mixture of several salts thereof for reducing the gastric acid secretion-stimulating effect of N-Acetyl-4-aminophenol (Paracetamol).

Use of homoeriodictyol (HED) for reducing the gastric acid secretion-stimulating effect of n-acetyl-4-aminophenol (Paracetamol)

The invention relates to compounds of formula (I) or the salts thereof, said compounds of formula (I) being selected from among the group consisting of homoeriodictyol (1), eriodictyol (2), hesperetin (3) and sterubin (4), for use in the treatment of an ailment which can be alleviated or prevented by influencing the serotonin level and the concentration of free fatty acids in the blood. 

Hydroxyflavanones as appetite stimulants

Pharmaceutical preparations are proposed, comprising bitter-masking acting substances for reducing and/or inhibiting gastric acid secretion induced by food constituents.

Pharmaceutical preparations

Suggested are new compositions for oral ingestion, comprising at least one active agent from the group of alkamides. The compositions which are orally ingested reduce the uptake of free fatty acids in the adipocytes and at the same time stimulate the release of serotonin and dopamine, which leads to a reduction of appetite, a feeling of satiety and a positive mood. In doing so, the new compositions are thus perfectly suitable to counteract any undesired gain of weight.

Oral compositions

Growing community of inventors

Weidling, Austria

Veronika Somoza